Additionally, we found that PNET metastatic sites were significantly enriched with cytotoxic CD8+ T cells, and the CD4/CD8 ratio of T cells isolated in metastatic sites were skewed from its ratio observed in peripheral blood, indicative of a tumor-driven immune response (Figure 5, G and H). This evidence concerns the gene CD8A and neoplasm.